Science & Technology

Adding technology that will enhance commercialization of our neuroscience-based innovative assistive technology platform for living with Alzheimer's disease and Alzheimer's disease related dementia

Department of Health and Human Services — National Institutes of Health

Opportunity #: 1SB1AG087924-01

Award Ceiling

$2.7M

Award Floor

$2.7M

Close Date

Apr 30, 2027

411 days left

Total Funding

$2.7M

Expected Awards

Posted Date

May 15, 2024

Cost Sharing Required

Grants.gov ID

sbir-1SB1AG087924-01

Description

SBIR Phase Phase II award: "Adding technology that will enhance commercialization of our neuroscience-based innovative assistive technology platform for living with Alzheimer's disease and Alzheimer's disease related dementia" awarded to MAPHABIT INC in ATLANTA, Georgia. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $2,660,575. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.